Atlas Trials

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Clinical trial NCT02273960 · COMPLETED

Trial details

NCT number
NCT02273960
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Immune Thrombocytopenic Purpura
Start date
2014-11-17
Primary completion
2018-01-22
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.